One thing is for certain in these uncertain times: recent U.S. administration policy directives have the potential to affect the biopharma landscape deeply. Shifts in trade policy, regulatory structures and public research funding have led to financial market volatility, uncertainty on the role and reliability of institutions and questions about how the industry will sustain innovation.

These changes, along with potential disruptions in drug pricing and marketing, present significant challenges. While predicting the exact future is difficult, the multitude of potential threats makes it crucial for industry leaders to plan and adapt proactively.

In this webinar, we cover:

• ZS’s perspective on the policy and regulatory themes that biopharma should be watching across the value chain
• Actions that industry leaders can take to navigate this era of uncertainty and sustain innovation in biopharma